Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia

International Journal of Neuropsychopharmacology

Volumn 15, Issue 1, 2012, Pages 69-76

  Lodge, Daniel J ^a   Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Amphetamine sensitization; associative striatum; dopamine; nucleus accumbens; schizophrenia; stress

Indexed keywords

AMPHETAMINE; CHLORAL HYDRATE; METHYLAZOXYMETHANOL ACETATE; CENTRAL STIMULANT AGENT; DOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL EXAMINATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG SENSITIZATION; HUMAN; IN VIVO STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; THALAMUS VENTRAL NUCLEUS; VENTRAL TEGMENTUM; ACTION POTENTIAL; ANIMAL; CORPUS STRIATUM; DISEASE MODEL; DRUG EFFECTS; DYSKINESIA; FEMALE; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINERGIC NEURONS; DYSKINESIA, DRUG-INDUCED; FEMALE; MALE; METHYLAZOXYMETHANOL ACETATE; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; VENTRAL TEGMENTAL AREA;

EID: 84856484885     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000113     Document Type: Article

References (33)

1. Abi-Dargham A (2004). Do we still believe in the dopamine hypothesis? New data bring new evidence. International Journal of Neuropsychopharmacology 7 (Suppl. 1), S1-S5. (Pubitemid 38436990)
2. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, et al. (2000). Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proceedings of the National Academy of Sciences USA 97, 8104-8109. (Pubitemid 30460780)
3. Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, et al. (2009). Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects. Biological Psychiatry 65, 1091-1093.
4. Angrist BM, Gershon S (1970). The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biological Psychiatry 2, 95-107.
5. Disclafani Ii A, Hall RCW, Gardner ER (1981). Drug induced psychosis: emergency diagnosis and management. Psychosomatics 22, 845-855. (Pubitemid 12206394)
6. Featherstone RE, Kapur S, Fletcher PJ (2007). The amphetamine-induced sensitized state as a model of schizophrenia. Progress in Neuro- Psychopharmacology and Biological Psychiatry 31, 1556-1571. (Pubitemid 47625703)
7. Floresco SB, Todd CL, Grace AA (2001). Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. Journal of Neuroscience 21, 4915-4922. (Pubitemid 32565650)
8. Floresco SB, West AR, Ash B, Moore H, et al. (2003). Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nature Neuroscience 6, 968-973. (Pubitemid 37064759)
9. Grace AA, Bunney BS (1983). Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 10, 301-315. (Pubitemid 13019570)
10. Grace AA, Bunney BS (1984). The control of firing pattern in nigral dopamine neurons: burst firing. Journal of Neuroscience 4, 2877-2890. (Pubitemid 15224432)
11. Grace AA, Bunney BS (1985). Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Research 333, 271-284. (Pubitemid 15093585)
12. Ikemoto S (2002). Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. Neuroscience 113, 939-955. (Pubitemid 35245262)
13. Ikemoto S (2004). Unconditional hyperactivity and transient reinforcing effects of NMDA administration into the ventral tegmental area in rats. Psychopharmacology (Berlin) 172, 202-210. (Pubitemid 38388770)
14. Ikemoto S (2007). Dopamine reward circuitry : two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Research Reviews 56, 27-78. (Pubitemid 350110353)
15. Ikemoto S, Glazier BS, Murphy JM, McBride WJ (1997). Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. Journal of Neuroscience 17, 8580-8587. (Pubitemid 27461078)
16. Janowsky DS, el-Yousel MK, Davis JM, Sekerke HJ (1973). Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Archives of General Psychiatry 28, 185-191.
17. Joyce EM, Koob GF, Strecker R (1981). The behavioural effects of enkephalin analogues injected into the ventral tegmental area and globus pallidus. Brain Research. Brain Research Reviews 221, 359-370. (Pubitemid 12196345)
18. Kapur S, Zipursky R, Jones C, Remington G, et al. (2000). Relationship between dopamine D2 occupancy, clinical response, and side effects : a double-blind PET study of first-episode schizophrenia. American Journal of Psychiatry 157, 514-520. (Pubitemid 30191189)
19. Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, et al. (2010). Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Archives of General Psychiatry 67, 231-239.
20. Laruelle M, Abi-Dargham A (1999). Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. Journal of Psychopharmacology 13, 358-371. (Pubitemid 30055180)
21. Laruelle M, Abi-Dargham A, Van Dyck CH, Gil R, et al. (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences USA 93, 9235-9240.
22. Lodge DJ, Grace AA (2006). The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology 31, 1356-1361.
23. Lodge DJ, Grace AA (2007). Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. Journal of Neuroscience 27, 11424-11430. (Pubitemid 47621327)
24. Lodge DJ, Grace AA (2008). Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: a mechanism of behavioral sensitization. Journal of Neuroscience 28, 7876-7882.
25. Lodge DJ, Grace AA (2009). Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia. Behavioral Brain Research 204, 306-312.
26. Meltzer HY, Matsubara S, Lee JC (1989a). Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pK(i) values. Journal of Pharmacology and Experimental Therapeutics 251, 238-246.
27. Meltzer HY, Matsubara S, Lee JC (1989b). The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacology Bulletin 25, 390-392. (Pubitemid 20260244)
28. Moore H, Jentsch JD, Ghajarnia M, Geyer MA, et al. (2006). A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biological Psychiatry 60, 253-264. (Pubitemid 44093447)
29. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press Australia.
30. Rodd-Henricks ZA, McKinzie DL, Li TK, Murphy JM, et al. (2002). Cocaine is self-administered into the shell but not the core of the nucleus accumbens of Wistar rats. Journal of Pharmacology and Experimental Therapeutics 303, 1216-1226. (Pubitemid 35424408)
31. Swanson CJ, Heath S, Stratford TR, Kelley AE (1997). Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacology Biochemistry and Behavior 58, 933-945. (Pubitemid 28108200)
32. Valenti O, Lodge DJ, Grace AA (in press). Aversive stimuli alter ventral tegmental area dopamine neuron activity via a common action in the ventral hippocampus. Journal of Neuroscience.
33. Zangen A, Solinas M, Ikemoto S, Goldberg SR, et al. (2006). Two brain sites for cannabinoid reward. Journal of Neuroscience 26, 4901-4907. (Pubitemid 44315331)